-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
Mini-review
(3989) Views (828) Full article downloads
Authors: Jørn Ditzel, Hans Henrik Lervang
Published Date October 2009
Volume 2009:2 Pages 173 - 177
DOI: http://dx.doi.org/10.2147/DMSO.S6338
Jørn Ditzel, Hans Henrik Lervang
Department of Endocrinology, and Center for Prevention of Struma and Metabolic Diseases, Aalborg University Hospital, Aarhus University, Denmark
Abstract: A paradoxical metabolic imbalance in inorganic phosphate occurs from the early onset of diabetes and may lead to a reduction of high energy phosphates and tissue hypoxia. These changes take place in the cells and tissues in which the entry of glucose is not controlled by insulin, and particularly in poorly regulated diabetes patients in whom long-term vascular complications are more likely to occur. Several therapeutic intervention trials have been carried out, including assessment of optimal glucose regulation, the effect of dietary inclusion of calcium diphosphate and pharmaceutical intake of etidronate disodium (EHDP), but none of these modalities wholly overcome the problem. The potential therapeutic application of fructose-1, 6-diphosphate, however, which also acts as human bioenergy, holds a great deal of promise as an efficacious and well-tolerated therapeutic regimen.
Keywords: diabetes, inorganic phosphate metabolism, early intervention trials
Other articles by Dr Hans-Henrik Lervang
Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Risk management in the treatment of type 2 diabetes with pioglitazone
Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms
Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Serum ferritin concentration in gestational diabetes mellitus and risk of subsequent development of early postpartum diabetes mellitus
Is obesity in women protective against osteoporosis?
Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer
Erratum
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- The economic impact of obesity in the United States
- Alogliptin: a new addition to the class of DPP-4 inhibitors
- Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
- Adipose inflammation: cause or consequence of obesity-related insulin resistance




